Maspin and MCM2 immunoprofiling in salivary gland carcinomas

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Ghazy, Shaimaa E ^a   Helmy, Iman M ^a   Baghdadi, Houry M ^a  

^a Ain Shams University   (Egypt)

Author keywords

Maspin; Mcm2; Salivary gland carcinomas

Indexed keywords

CELL CYCLE PROTEIN; MCM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PLEOMORPHIC ADENOMA; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; CELL CYCLE PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NUCLEAR PROTEINS; SALIVARY GLAND NEOPLASMS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053369695     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-89     Document Type: Article

References (45)

1. Speight P, Barrett A. Salivary gland tumors. Oral Dis 2002, 8:229-240. 10.1034/j.1601-0825.2002.02870.x, 12363107.
2. Barnes L, Eveson J, Reichart P, Sidransky D. Salivary glands. Pathology and genetics of head and neck tumors 2005, 212-213. Lyon: IARC Press, Barnes L.
3. Schwarz S, Ettl T, Kleinsasser K, Hartmann A, Reichert T, Driemel O. Loss of maspin expression is a negative prognostic factor in common salivary gland tumors. Oral Oncol 2008, 44:563-570. 10.1016/j.oraloncology.2007.07.004, 17936671.
4. Xia W, Lau Y, Hu M, Li L, Johnston D, Sheng S, El-Naggar A, Hung M. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 2000, 19:2398-2403. 10.1038/sj.onc.1203535, 10828881.
5. Bailey C, Khalkhali-Ellis Z, Seftor E, Hendrix M. Biological functions of maspin. J Cell Physi 2006, 209:617-624.
6. Sheng S, Truong B, Fredrickson D, Wu R, Pardee A, Sager R. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci 1998, 95:499-504. 10.1073/pnas.95.2.499, 18448, 9435220.
7. Bass R, Fernandez A, Ellis V. Maspin inhibits cell migration in the absence of protease inhibitory activity. J Biol Chem 2002, 277:46845-46848. 10.1074/jbc.C200532200, 12384513.
8. Ngamkitidechakul C, Burke J, O'Brien W, Twining S. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Invest Ophthalmol Vis Sci 2001, 42:3135-3141.
9. Reis-Filho J, Torio B, Albergaria A, Schmitt F. Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch 2002, 441:551-558. 10.1007/s00428-002-0710-1, 12461611.
10. Yatabe Y, Mitsudomi T, Takahashi T. Maspin expression in normal lung and non-small cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation. Oncogene 2004, 23:4041-4049. 10.1038/sj.onc.1207557, 15048080.
11. Nicolai M, Martin Z, Koichi N, Pierre R. Maspin locates to the nucleus in certain cell types. J Pathol 2002, 197:274-275.
12. Khalkhali-Ellis Z, Hendrix M. Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol 2003, 162:1411-1417. 10.1016/S0002-9440(10)64274-5, 1851188, 12707024.
13. Mandlekar S, Kong A. Mechanism of tamoxifen induced apoptosis. Apoptosis 2001, 6:469-477. 10.1023/A:1012437607881, 11595837.
14. Cher M, Biliran H, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S. Maspin expression inhibits osteolysis, tumor growth and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci 2003, 100:7847-7852. 10.1073/pnas.1331360100, 164676, 12788977.
15. Navarro R, Martins M, de Arau' jo V. Maspin expression in normal and neoplastic salivary gland. J Oral Pathol Med 2004, 33:435-440. 10.1111/j.1600-0714.2004.00220.x, 15250837.
16. Sheng S, Carey J, Seftor E, Dias L, Hendrix M, Sager R. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci 1996, 93:11669-11674. 10.1073/pnas.93.21.11669, 38116, 8876194.
17. Nickoloff B, Lingen M, Chang B, Shen M, Swift M, Curry J, Bacon P, Bodner B, Roninson I. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 2004, 64:2956-2961. 10.1158/0008-5472.CAN-03-2388, 15126325.
18. Zhang M, Volpert O, Shi Y, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med 2000, 6:196-199. 10.1038/72303, 10655109.
19. Solomon L, Munkarah A, Schimp V, Arabi M, Morris R, Nassar H, Ali-Fehmi R. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Gynecol Oncol 2006, 101:385-389. 10.1016/j.ygyno.2005.11.049, 16443262.
20. Jiang N, Meng Y, Zhang S, Mensah-Osman E, Sheng S. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002, 21:4089-4098. 10.1038/sj.onc.1205507, 12037665.
21. Duan S, Hajek P, Lin C, Shin S, Attardi G, Chomyn A. Mitochondrial outer membrane permeability change and hypersensitivity to digitonin early in staurosporine-induced apoptosis. J Biol Chem 2003, 278:1346-1353. 10.1074/jbc.M209269200, 12403774.
22. Sheng S. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge. J Cell Physi 2006, 209:631-635.
23. Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi K, Tomita K, Komiyama S. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 2001, 23:962-966. 10.1002/hed.1139, 11754500.
24. Lonardo F, Li X, Siddiq F, Singh R, Al-Abbadi M, Pass H, Sheng S. Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. Lung Cancer 2006, 51:31-39. 10.1016/j.lungcan.2005.07.011, 16159682.
25. Stefan M, Jürgen S, Carsten B, Wolfgang B, Antje M, Christian K, Jörg H, Ruth K, Masahiko K, Udo J, Markus K. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 2001, 95:337-342. 10.1002/1097-0215(20010920)95:5<337::AID-IJC1059>3.0.CO;2-1, 11494236.
26. Forsburg S. Eukaryotic MCM proteins: beyond replication initiation. Microbiol Mol Biol Rev 2004, 68:109-131. 10.1128/MMBR.68.1.109-131.2004, 362110, 15007098.
27. Blow J, Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Biol 2005, 6:476-486.
28. Madine M, Swietlik M, Pelizon C, Romanowski P, Mills A, Laskey R. The roles of the MCM, ORC and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. J Struct Biol 2000, 129:198-210. 10.1006/jsbi.2000.4218, 10806069.
29. Going J, Keith W, Neilson L, Stoeber K, Stuart R, Williams G. Aberrant expression of minichromosome maintenance proteins 2 and 5 and Ki-67 in dysplastic squamous esophageal epithelium and Barrett's mucosa. Gut 2002, 50:373-377. 10.1136/gut.50.3.373, 1773132, 11839717.
30. Alison M, Hunt T, Forbes S. Minichromosome maintenance (MCM) proteins may be pre-cancer markers. Gut 2002, 50:290-291. 10.1136/gut.50.3.290, 1773123, 11839701.
31. Fanshawe T, Prevost A, Sainsbury R, Williams G, Stoeber K. DNA replication licensing and cell cycle kinetics of normal and neoplastic breast. Brit J Cancer 2005, 93:1295-1300. 10.1038/sj.bjc.6602829, 2361513, 16278669.
32. Lei M, Tye B. Initiating DNA synthesis: from recruiting to activating the MCM complex. J Cell Sci 2001, 14:1447-1454.
33. Tan D, Huberman J, Hyland A, Loewen G, Brooks J, Beck A, Todorov I, Bepler G. MCM2 a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer 2001, 1:1-6. 10.1186/1471-2407-1-1, 32169, 11231886.
34. Vargas P, Cheng W, Barrett A, Craig G, Speight P. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumors. J Oral Pathol Med 2008, 37:309-318. 10.1111/j.1600-0714.2007.00631.x, 18248354.
35. Stoeber K, Tlsty T, Happerfield L, Thomas G, Romanov S, Bobrow L, Williams E, Williams G. DNA replication, licensing and human cell proliferation. J Cell Sci 2001, 114:2027-2041.
36. Sood A, Fletcher M, Gruman L, Coffin J, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor E, Hendrix M. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002, 8:2924-2932.
37. Yamaguchi N, Ito E, Azuma S, Honma R, Yanagisawa Y, Nishikawa A, Kawamura M, Imai J, Tatsuta K, Inoue K, Semba K, Watanabe S. Fox A1 as a lineage-specific oncogene in luminal type breast cancer. Biochem Biophys Res Commun 2008, 365:711-717. 10.1016/j.bbrc.2007.11.064, 18039470.
38. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J Pathol 2001, 195:321-326. 10.1002/path.948, 11673829.
39. Reis-Filho J, Milanezi F, Silva P, Schmitt F. Maspin expression in myoepithelial tumors of the breast. Pathol Res Pract 2001, 197:817-821. 10.1078/0344-0338-00165, 11795829.
40. Takahashi S, Nakamura S, Shinzato K, Domon T, Yamamoto T, Wakita M. Apoptosis and proliferation of myoepithelial cells in atrophic rat submandibular glands. J Histochem Cytochem 2000, 49:1557-1564.
41. Wang Z, Herrington B, Schwartz M, Laucirica R. Myoepithelial carcinoma of the parotid gland metastatic to the kidney: case report and review of the literature. Diag Cytopathol 2010, 38(suppl 4):279-282.
42. Savera A, Sloman A, Huvos A, Klimstra D. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol 2000, 24:761-774. 10.1097/00000478-200006000-00001, 10843278.
43. Jaehne M, Roeser K, Jaekel T, Schepers J, Albert N, Loning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 2005, 103:2526-33. 10.1002/cncr.21116, 15900577.
44. Umekita Y, Ohi Y, Sagara Y, Yoshida H. Expression of maspin predicts poor prognosis in breast cancer patients. Int J Cancer 2002, 100:452-455. 10.1002/ijc.10500, 12115529.
45. Guzinska-Ustymowiczi K, Pryczyiczi A, Kemonai A, Czyzewska J. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Anticancer Res 2009, 29:3049-3052.